| RVACX | VEVYX | RVACX / VEVYX | |
| Total Expense Ratio | 2.07 | 0.66 | 314% |
| Annual Report Gross Expense Ratio | 3.21 | 0.66 | 486% |
| Fund Existence | 19 years | 13 years | - |
| Gain YTD | 5.699 | 11.746 | 49% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 250M | 15.2B | 2% |
| Annual Yield % from dividends | 0.14 | 1.20 | 12% |
| Returns for 1 year | 1.07 | 13.08 | 8% |
| Returns for 3 years | -0.13 | 15.96 | -1% |
| Returns for 5 years | -17.57 | 8.11 | -217% |
| Returns for 10 years | -24.32 | 73.19 | -33% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBP | 91.63 | 1.62 | +1.80% |
| Virtus LifeSci Biotech Products ETF | |||
| OPTZ | 49.36 | 0.62 | +1.26% |
| Optimize Strategy Index ETF | |||
| EUFN | 39.10 | 0.37 | +0.96% |
| iShares MSCI Europe Financials ETF | |||
| ABLD | 30.24 | -0.02 | -0.05% |
| Abacus FCF Real Assets Leaders ETF | |||
| FGDL | 55.84 | -0.30 | -0.53% |
| Franklin Responsibly Sourced Gold ETF | |||